| 1 |
Popek-marciniec S, Styk W, Wojcierowska-litwin M, Szudy-szczyrek A, Dudek P, Swiderska-kolacz G, Czerwik-marcinkowska J, Zmorzynski S. The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. JCM 2023;12:2384. [DOI: 10.3390/jcm12062384] [Reference Citation Analysis]
|
| 2 |
Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell 2023:S0092-8674(23)00163-0. [PMID: 36924769 DOI: 10.1016/j.cell.2023.02.020] [Reference Citation Analysis]
|
| 3 |
Kumar VB, Ozguney B, Vlachou A, Chen Y, Gazit E, Tamamis P. Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery. J Phys Chem B 2023;127:1857-71. [PMID: 36812392 DOI: 10.1021/acs.jpcb.2c06751] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Cheruku S, Rao V, Pandey R, Rao Chamallamudi M, Velayutham R, Kumar N. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy. Int Immunopharmacol 2023;116:109569. [PMID: 36773572 DOI: 10.1016/j.intimp.2022.109569] [Reference Citation Analysis]
|
| 5 |
Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat Rev Urol 2023;20:133-57. [PMID: 36414800 DOI: 10.1038/s41585-022-00676-0] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 6 |
Okuyama K, Suzuki K, Yanamoto S. Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer. Cancers (Basel) 2023;15. [PMID: 36831453 DOI: 10.3390/cancers15041111] [Reference Citation Analysis]
|
| 7 |
Sharpe MA, Baskin DS, Johnson RD, Baskin AM. Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts. Int J Mol Sci 2023;24. [PMID: 36834607 DOI: 10.3390/ijms24043198] [Reference Citation Analysis]
|
| 8 |
Cho SK, Lee K, Woo JH, Choi JH. Macrophages Promote Ovarian Cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells. Cells 2023;12. [PMID: 36766725 DOI: 10.3390/cells12030384] [Reference Citation Analysis]
|
| 9 |
Jiang F, Jiang S, Cao D, Mao M, Xiang Y. Immunologic Signatures across Molecular Subtypes and Potential Biomarkers for Sub-Stratification in Endometrial Cancer. Int J Mol Sci 2023;24. [PMID: 36675305 DOI: 10.3390/ijms24021791] [Reference Citation Analysis]
|
| 10 |
Li J, Yao Z, Liu X, Duan R, Yi X, Ayoub A, Sanders JO, Mesfin A, Xing L, Boyce BF. TGFβ1(+)CCR5(+) neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice. Nat Commun 2023;14:159. [PMID: 36631487 DOI: 10.1038/s41467-023-35801-z] [Reference Citation Analysis]
|
| 11 |
Talayero VC, Vicente-Manzanares M. A primer on cancer-associated fibroblast mechanics and immunosuppressive ability. Explor Target Antitumor Ther 2023;4:17-27. [PMID: 36937319 DOI: 10.37349/etat.2023.00120] [Reference Citation Analysis]
|
| 12 |
Mecklenbrauck R, Heuser M. Resistance to targeted therapies in acute myeloid leukemia. Clin Exp Metastasis 2023;40:33-44. [PMID: 36318439 DOI: 10.1007/s10585-022-10189-0] [Reference Citation Analysis]
|
| 13 |
Jenei V, Burai S, Molnár T, Kardos B, Mácsik R, Tóth M, Debreceni Z, Bácsi A, Mázló A, Koncz G. Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells. Cancer Chemother Pharmacol 2023;91:53-66. [PMID: 36451019 DOI: 10.1007/s00280-022-04497-1] [Reference Citation Analysis]
|
| 14 |
Wang Y, Huang G, Hou Q, Pan H, Cai L. Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;:e1875. [PMID: 36567668 DOI: 10.1002/wnan.1875] [Reference Citation Analysis]
|
| 15 |
Domingos-Pereira S, Sathiyanadan K, Polak L, Haefliger JA, Schmittnaegel M, Ries CH, Jichlinski P, Roth B, Derré L, Nardelli-Haefliger D. Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies. Int J Mol Sci 2022;24. [PMID: 36613562 DOI: 10.3390/ijms24010123] [Reference Citation Analysis]
|
| 16 |
Greenberg J, Limberg J, Verma A, Kim D, Chen X, Lee YJ, Moore MD, Ullmann TM, Thiesmeyer JW, Loewenstein Z, Chen KJ, Egan CE, Stefanova D, Bareja R, Zarnegar R, Finnerty BM, Scognamiglio T, Du YN, Elemento O, Fahey TJ 3rd, Min IM. Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration. JCI Insight 2022;7. [PMID: 36301668 DOI: 10.1172/jci.insight.160130] [Reference Citation Analysis]
|
| 17 |
Przygodzka P, Soboska K, Sochacka E, Pacholczyk M, Braun M, Kassassir H, Papiewska-Pająk I, Kielbik M, Boncela J. Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment. Cell Commun Signal 2022;20:193. [PMID: 36482448 DOI: 10.1186/s12964-022-01003-1] [Reference Citation Analysis]
|
| 18 |
Li R, Xue K, Li J. FGF13 suppresses acute myeloid leukemia by regulating bone marrow niches. Front Med 2022;16:896-908. [PMID: 36053411 DOI: 10.1007/s11684-022-0944-z] [Reference Citation Analysis]
|
| 19 |
Hunter P, Payne-Dwyer AL, Shaw M, Signoret N, Leake MC. Single-molecule and super-resolved imaging deciphers membrane behavior of onco-immunogenic CCR5. iScience 2022;25:105675. [PMID: 36561885 DOI: 10.1016/j.isci.2022.105675] [Reference Citation Analysis]
|
| 20 |
Brett E, Duscher D, Pagani A, Daigeler A, Kolbenschlag J, Hahn M. Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment. Int J Mol Sci 2022;23. [PMID: 36430633 DOI: 10.3390/ijms232214159] [Reference Citation Analysis]
|
| 21 |
Franzese O, Graziani G. Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. Cancers (Basel) 2022;14. [PMID: 36428727 DOI: 10.3390/cancers14225633] [Reference Citation Analysis]
|
| 22 |
O’connor GM, Bakker EY. Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma. BioMedInformatics 2022;2:580-592. [DOI: 10.3390/biomedinformatics2040037] [Reference Citation Analysis]
|
| 23 |
Zhang P, Du Y, Bai H, Wang Z, Duan J, Wang X, Zhong J, Wan R, Xu J, He X, Wang D, Fei K, Yu R, Tian J, Wang J. Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors. BMC Med 2022;20:435. [PMID: 36352411 DOI: 10.1186/s12916-022-02598-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Li Y, Lei Y, Sun J, Zhang W, Li X, Chen S, Kong D, Chen C, Bi K, Luo X, Wang H, Li B, Luo H, Xu Y. A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1020400] [Reference Citation Analysis]
|
| 25 |
Hamidi Y, Aliasgari E, Basimi P, Sajadipour M, Baesi K. Immune-Related Gene Profile in HIV-Infected Patients with Discordant Immune Response. Iran Biomed J 2022;26:485-91. [PMID: 36380676 DOI: 10.52547/ibj.3750] [Reference Citation Analysis]
|
| 26 |
Svirshchevskaya EV, Konovalova MV, Snezhkov EV, Poltavtseva RA, Akopov SB. Chemokine Homeostasis in Healthy Volunteers and during Pancreatic and Colorectal Tumor Growth in Murine Models. Curr Issues Mol Biol 2022;44:4987-99. [PMID: 36286054 DOI: 10.3390/cimb44100339] [Reference Citation Analysis]
|
| 27 |
Wu Z, Yu X, Zhang S, He Y, Guo W. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer. Front Immunol 2022;13:951561. [DOI: 10.3389/fimmu.2022.951561] [Reference Citation Analysis]
|
| 28 |
Griffiths JI, Cosgrove PA, Castaneda EM, Nath A, Chen J, Adler FR, Chang JT, Khan QJ, Bild AH. Cancer cells communicate with macrophages to prevent T cell activation during development of cell cycle therapy resistance.. [DOI: 10.1101/2022.09.14.507931] [Reference Citation Analysis]
|
| 29 |
Chen R, Wu W, Liu T, Zhao Y, Wang Y, Zhang H, Wang Z, Dai Z, Zhou X, Luo P, Zhang J, Liu Z, Zhang L, Cheng Q. Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas. Front Immunol 2022;13:914001. [DOI: 10.3389/fimmu.2022.914001] [Reference Citation Analysis]
|
| 30 |
Mejía-Hernández JO, Keam SP, Saleh R, Muntz F, Fox SB, Byrne D, Kogan A, Pang L, Huynh J, Litchfield C, Caramia F, Lozano G, He H, You JM, Sandhu S, Williams SG, Haupt Y, Haupt S. Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss. Cell Death Dis 2022;13:777. [PMID: 36075907 DOI: 10.1038/s41419-022-05211-y] [Reference Citation Analysis]
|
| 31 |
Lu Y, Zhao M, Mo J, Lan G, Liang J. Dietary supplementation ellagic acid on the growth, intestinal immune response, microbiota, and inflammation in weaned piglets. Front Vet Sci 2022;9. [DOI: 10.3389/fvets.2022.980271] [Reference Citation Analysis]
|
| 32 |
Lu M, Lee Y, Lillehoj HS. Evolution of developmental and comparative immunology in poultry: The regulators and the regulated. Dev Comp Immunol 2022;:104525. [PMID: 36058383 DOI: 10.1016/j.dci.2022.104525] [Reference Citation Analysis]
|
| 33 |
Belli C, Antonarelli G, Repetto M, Boscolo Bielo L, Crimini E, Curigliano G. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies. Cancers 2022;14:4278. [DOI: 10.3390/cancers14174278] [Reference Citation Analysis]
|
| 34 |
Spunde K, Korotkaja K, Zajakina A. Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. Biomedicines 2022;10:2142. [DOI: 10.3390/biomedicines10092142] [Reference Citation Analysis]
|
| 35 |
Li R, Wu X, Xue K, Li J. ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia. Cancer Cell Int 2022;22:268. [PMID: 35999614 DOI: 10.1186/s12935-022-02684-x] [Reference Citation Analysis]
|
| 36 |
Wang X, Xu D, Chen B, Huang D, Li Z, Sui Y, Lin F, Yao H, Li HY, Lin X, Li T. Delicaflavone Represses Lung Cancer Growth by Activating Antitumor Immune Response through N6-Methyladenosine Transferases and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/8619275] [Reference Citation Analysis]
|
| 37 |
Momboisse F, Nardi G, Colin P, Hery M, Cordeiro N, Blachier S, Schwartz O, Arenzana-Seisdedos F, Sauvonnet N, Olivio-Marin JC, Lagane B, Lagache T, Brelot A. Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status. Elife 2022;11:e76281. [PMID: 35866628 DOI: 10.7554/eLife.76281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
van Eekeren LE, Matzaraki V, Zhang Z, van de Wijer L, Blaauw MJT, de Jonge MI, Vandekerckhove L, Trypsteen W, Joosten LAB, Netea MG, de Mast Q, Koenen HJPM, Li Y, van der Ven AJAM. People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells. Sci Rep 2022;12:11425. [PMID: 35794176 DOI: 10.1038/s41598-022-15646-0] [Reference Citation Analysis]
|
| 39 |
Damian L, Login CC, Solomon C, Belizna C, Encica S, Urian L, Jurcut C, Stancu B, Vulturar R. Inclusion Body Myositis and Neoplasia: A Narrative Review. IJMS 2022;23:7358. [DOI: 10.3390/ijms23137358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Chairani E, Fuchigami T, Koyama H, Ono Y, Iijima M, Kishida M, Kibe T, Nakamura N, Kishida S. Intercellular signaling between ameloblastoma and osteoblasts. Biochemistry and Biophysics Reports 2022;30:101233. [DOI: 10.1016/j.bbrep.2022.101233] [Reference Citation Analysis]
|
| 41 |
Chen K, Wang Y, Hou Y, Wang Q, Long D, Liu X, Tian X, Yang Y. Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Zhou J, Wang L, Peng C, Peng F. Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. Front Pharmacol 2022;13:886198. [DOI: 10.3389/fphar.2022.886198] [Reference Citation Analysis]
|
| 43 |
Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm (2020) 2022;3:e147. [PMID: 35702353 DOI: 10.1002/mco2.147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Xu ZJ, Jin Y, Zhang XL, Xia PH, Wen XM, Ma JC, Lin J, Qian J. Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia. Cancer Med 2023;12:789-807. [PMID: 35642341 DOI: 10.1002/cam4.4905] [Reference Citation Analysis]
|
| 45 |
Huang Y, Liu H, Liu X, Li N, Bai H, Guo C, Xu T, Zhu L, Liu C, Xiao J. The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC. Front Genet 2022;13:820065. [DOI: 10.3389/fgene.2022.820065] [Reference Citation Analysis]
|
| 46 |
Raghavakaimal A, Cristofanilli M, Tang C, Alpaugh RK, Gardner KP, Chumsri S, Adams DL. CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome. Breast Cancer Res 2022;24. [DOI: 10.1186/s13058-022-01528-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Hunter P, Payne-dwyer AL, Shaw M, Signoret N, Leake MC. Single-molecule and super-resolved imaging deciphers membrane behaviour of onco-immunogenic CCR5.. [DOI: 10.1101/2022.05.19.492692] [Reference Citation Analysis]
|
| 48 |
Larroquette M, Guegan JP, Besse B, Cousin S, Brunet M, Le Moulec S, Le Loarer F, Rey C, Soria JC, Barlesi F, Bessede A, Scoazec JY, Soubeyran I, Italiano A. Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies. J Immunother Cancer 2022;10. [PMID: 35618288 DOI: 10.1136/jitc-2021-003890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 49 |
Isik Z, Leblebici A, Demir Karaman E, Karaca C, Ellidokuz H, Koc A, Ellidokuz EB, Basbinar Y. In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps. PLoS ONE 2022;17:e0267973. [DOI: 10.1371/journal.pone.0267973] [Reference Citation Analysis]
|
| 50 |
Wang L, Jiang J, Chen Y, Jia Q, Chu Q. The roles of CC chemokines in response to radiation. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02038-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 51 |
Monga S, Fares B, Yashaev R, Melamed D, Kahana M, Fares F, Weizman A, Gavish M. The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation. J Fungi (Basel) 2022;8:321. [PMID: 35330323 DOI: 10.3390/jof8030321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Wang Y, Shi H, Zhang Y, Zeng Q, Chen T, Chai C. Identification of Differentially Expressed Hub Genes Associated With Immune Cell Recruitment in Claudin-Low Breast Cancer. Front Oncol 2022;12:848206. [DOI: 10.3389/fonc.2022.848206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Huang L, Ding Z, Zhang Y. CD24+ MDSC-DCs Induced by CCL5-Deficiency Showed Improved Antitumor Activity as Tumor Vaccines. Glob Med Genet. [DOI: 10.1055/s-0042-1743569] [Reference Citation Analysis]
|
| 54 |
Gao LF, Zhong Y, Long T, Wang X, Zhu JX, Wang XY, Hu ZY, Li ZG. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling. J Exp Clin Cancer Res 2022;41:81. [PMID: 35241150 DOI: 10.1186/s13046-022-02300-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 55 |
Zhang PF, Wang C, Zhang L, Li Q. Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells. Immunotherapy 2022. [PMID: 35232284 DOI: 10.2217/imt-2021-0228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Lou Y, Jia S, Liu P, Xu LX. CCL5 Deficiency Enhanced Cryo–Thermal-Triggered Long-Term Anti-Tumor Immunity in 4T1 Murine Breast Cancer. Biomedicines 2022;10:559. [DOI: 10.3390/biomedicines10030559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
White LG, Goy HE, Rose AJ, McLellan AD. Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours. Cancers (Basel) 2022;14:978. [PMID: 35205725 DOI: 10.3390/cancers14040978] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 58 |
Boyer S, Lee HJ, Steele N, Zhang L, Sajjakulnukit P, Andren A, Ward MH, Singh R, Basrur V, Zhang Y, Nesvizhskii AI, Pasca di Magliano M, Halbrook CJ, Lyssiotis CA. Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway. Elife 2022;11:e73796. [PMID: 35156921 DOI: 10.7554/eLife.73796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 59 |
Urbanova M, Buocikova V, Trnkova L, Strapcova S, Kajabova VH, Melian EB, Novisedlakova M, Tomas M, Dubovan P, Earl J, Bizik J, Svastova E, Ciernikova S, Smolkova B. DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Int J Mol Sci 2022;23:2117. [PMID: 35216235 DOI: 10.3390/ijms23042117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 60 |
Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. OncoImmunology 2022;11:2029298. [DOI: 10.1080/2162402x.2022.2029298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 61 |
Mielcarska S, Kula A, Dawidowicz M, Kiczmer P, Chrabańska M, Rynkiewicz M, Wziątek-kuczmik D, Świętochowska E, Waniczek D. Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study. Medicina 2022;58:203. [DOI: 10.3390/medicina58020203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
Bleve A, Consonni FM, Porta C, Garlatti V, Sica A. Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. Cancers (Basel) 2022;14:510. [PMID: 35158779 DOI: 10.3390/cancers14030510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 63 |
Hourani T, Holden JA, Li W, Lenzo JC, Hadjigol S, O'Brien-Simpson NM. Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting. Front Oncol 2021;11:788365. [PMID: 34988021 DOI: 10.3389/fonc.2021.788365] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 64 |
Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 34997230 DOI: 10.1038/s41571-021-00588-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 42.0] [Reference Citation Analysis]
|
| 65 |
Yuan P, Zhou Y, Wang Z, Gui L, Ma B. Dendritic cell-targeting chemokines inhibit colorectal cancer progression. Explor Target Antitumor Ther 2022;3:828-40. [PMID: 36654820 DOI: 10.37349/etat.2022.00115] [Reference Citation Analysis]
|
| 66 |
Elemam NM, Khalil BA, Maghazachi AA. Chemokines and Chemokine Receptors. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00061-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Isaikina P, Tsai C, Petrovic I, Rogowski M, Dürr AM, Grzesiek S. Preparation of a stable CCL5·CCR5·Gi signaling complex for Cryo-EM analysis. Biomolecular Interactions Part B 2022. [DOI: 10.1016/bs.mcb.2022.03.001] [Reference Citation Analysis]
|
| 68 |
Raza S, Rajak S, Tewari A, Gupta P, Chattopadhyay N, Sinha RA, Chakravarti B. Multifaceted role of chemokines in solid tumors: From biology to therapy. Semin Cancer Biol 2022;86:1105-21. [PMID: 34979274 DOI: 10.1016/j.semcancer.2021.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 69 |
Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, Simpson RM, Unni AM, Lam WL, Lam S, Abraham N, Bennewith KL, Lockwood WW. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. OncoImmunology 2022;11:2010905. [DOI: 10.1080/2162402x.2021.2010905] [Reference Citation Analysis]
|
| 70 |
Momboisse F, Nardi G, Colin P, Hery M, Cordeiro N, Schwartz O, Sauvonnet N, Arenzana-seisdedos F, Lagache T, Lagane B, Olivo-marin J, Brelot A. Single-molecule imaging reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status.. [DOI: 10.1101/2021.12.20.473455] [Reference Citation Analysis]
|
| 71 |
Tiberti S, Catozzi C, Scirgolea C, Croci O, Ballerini M, Cagnina D, Soriani C, Nava Lauson CB, Macandog AD, Bertalot G, Petz WL, Ravenda SP, Licursi V, Paci P, Rasponi M, Fazio N, Ren G, Fumagalli-romario U, Shaefer MH, Campaner S, Lugli E, Nezi L, Manzo T. GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in early-stage colorectal tumors and predict poor clinical outcome.. [DOI: 10.1101/2021.12.14.472046] [Reference Citation Analysis]
|
| 72 |
Diehl V, Huber LS, Trebicka J, Wygrecka M, Iozzo RV, Schaefer L. The Role of Decorin and Biglycan Signaling in Tumorigenesis. Front Oncol 2021;11:801801. [DOI: 10.3389/fonc.2021.801801] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 73 |
Sunaga N, Miura Y, Kasahara N, Sakurai R. Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer. Cancers (Basel) 2021;13:5956. [PMID: 34885068 DOI: 10.3390/cancers13235956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Tsai HC, Lai YY, Hsu HC, Fong YC, Lien MY, Tang CH. CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis. Int J Mol Sci 2021;22:12737. [PMID: 34884541 DOI: 10.3390/ijms222312737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 75 |
Wang J, Uddin MN, Hao JP, Chen R, Xiang YX, Xiong DQ, Wu Y. Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia. Front Genet 2021;12:723001. [PMID: 34777462 DOI: 10.3389/fgene.2021.723001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 76 |
Wang X, Chi H, Zhang Y, Li Z, Qu H, Xia Z, Li Q. Temporal analysis the acetylation and cytokine levels of the Cronobacter muytjensii infection brain based on a bioluminescence mouse model. J Neuroimmunol 2021;360:577722. [PMID: 34583093 DOI: 10.1016/j.jneuroim.2021.577722] [Reference Citation Analysis]
|
| 77 |
Yi J, Zhong W, Wu H, Feng J, Zouxu X, Huang X, Li S, Shuang Z. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer. Front Oncol 2021;11:746058. [PMID: 34745969 DOI: 10.3389/fonc.2021.746058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 78 |
Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 79 |
Deng Y, Jiang Z, Jin Y, Qiao J, Yang S, Xiong H, Yao J. Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment. J Control Release 2021;340:87-101. [PMID: 34662587 DOI: 10.1016/j.jconrel.2021.10.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 80 |
Hafezi S, Saber-Ayad M, Abdel-Rahman WM. Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma. Int J Mol Sci 2021;22:10219. [PMID: 34638560 DOI: 10.3390/ijms221910219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 81 |
Sionov RV. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled. Cells 2021;10:2486. [PMID: 34572138 DOI: 10.3390/cells10092486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 82 |
Boyer SM, Lee H, Steele NG, Zhang L, Sajjakulnukit P, Andren A, Ward MH, Basrur V, Zhang Y, Nesvizhskii AI, di Magliano MP, Halbrook CJ, Lyssiotis CA. Multi-omic Characterization of Pancreatic Cancer-Associated Macrophage Polarization Reveals Deregulated Metabolic Programs Driven by the GMCSF-PI3K Pathway.. [DOI: 10.1101/2021.09.10.459752] [Reference Citation Analysis]
|
| 83 |
Sun X, Chen Z. Cancer-associated fibroblast-derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression. Oncol Lett 2021;22:696. [PMID: 34457051 DOI: 10.3892/ol.2021.12957] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 84 |
Alluri SR, Higashi Y, Kil KE. PET Imaging Radiotracers of Chemokine Receptors. Molecules 2021;26:5174. [PMID: 34500609 DOI: 10.3390/molecules26175174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
Mladinich MC, Conde JN, Schutt WR, Sohn SY, Mackow ER. Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells. mBio 2021;12:e0196221. [PMID: 34399621 DOI: 10.1128/mBio.01962-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 86 |
Lapuente-Santana Ó, van Genderen M, Hilbers PAJ, Finotello F, Eduati F. Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. Patterns (N Y) 2021;2:100293. [PMID: 34430923 DOI: 10.1016/j.patter.2021.100293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 87 |
Broadway R, Patel NM, Hillier LE, El-Briri A, Korneva YS, Zinovkin DA, Pranjol MZI. Potential Role of Diabetes Mellitus-Associated T Cell Senescence in Epithelial Ovarian Cancer Omental Metastasis. Life (Basel) 2021;11:788. [PMID: 34440532 DOI: 10.3390/life11080788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Too NSH, Ho NCW, Adine C, Iyer NG, Fong ELS. Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models. Adv Drug Deliv Rev 2021;175:113791. [PMID: 33965462 DOI: 10.1016/j.addr.2021.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 89 |
Pfab C, Schnobrich L, Eldnasoury S, Gessner A, El-Najjar N. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know? Cancers (Basel) 2021;13:3193. [PMID: 34206772 DOI: 10.3390/cancers13133193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 90 |
Vasiukov G, Menshikh A, Owens P, Novitskaya T, Hurley P, Blackwell T, Feoktistov I, Novitskiy SV. Adenosine/TGFβ axis in regulation of mammary fibroblast functions. PLoS One 2021;16:e0252424. [PMID: 34101732 DOI: 10.1371/journal.pone.0252424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 91 |
Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunol Rev 2021;302:241-58. [PMID: 34075584 DOI: 10.1111/imr.12982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 92 |
Zhang J, He T, Xue L, Guo H. Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine 2021;68:103409. [PMID: 34049248 DOI: 10.1016/j.ebiom.2021.103409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 93 |
Lah Turnšek T, Jiao X, Novak M, Jammula S, Cicero G, Ashton AW, Joyce D, Pestell RG. An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5. Int J Mol Sci 2021;22:4464. [PMID: 33923334 DOI: 10.3390/ijms22094464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 94 |
Cendrowicz E, Sas Z, Bremer E, Rygiel TP. The Role of Macrophages in Cancer Development and Therapy. Cancers (Basel) 2021;13:1946. [PMID: 33919517 DOI: 10.3390/cancers13081946] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 95 |
Cinier J, Hubert M, Besson L, Di Roio A, Rodriguez C, Lombardi V, Caux C, Ménétrier-Caux C. Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them? Cancers (Basel) 2021;13:1850. [PMID: 33924428 DOI: 10.3390/cancers13081850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 96 |
Casagrande N, Borghese C, Agostini F, Durante C, Mazzucato M, Colombatti A, Aldinucci D. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel. Int J Mol Sci 2021;22:3019. [PMID: 33809553 DOI: 10.3390/ijms22063019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 97 |
Benedicto A, Hernandez-Unzueta I, Sanz E, Márquez J. Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma. Nutrients 2021;13:686. [PMID: 33669949 DOI: 10.3390/nu13020686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 98 |
Detering L, Abdilla A, Luehmann HP, Williams JW, Huang LH, Sultan D, Elvington A, Heo GS, Woodard PK, Gropler RJ, Randolph GJ, Hawker CJ, Liu Y. CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography. Mol Pharm 2021;18:1386-96. [PMID: 33591187 DOI: 10.1021/acs.molpharmaceut.0c01183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 99 |
Lapuente-santana Ó, van Genderen M, Hilbers P, Finotello F, Eduati F. Predictive systems biomarkers of response to immune checkpoint inhibitors.. [DOI: 10.1101/2021.02.05.429977] [Reference Citation Analysis]
|
| 100 |
Zaarour RF, Azakir B, Hajam EY, Nawafleh H, Zeinelabdin NA, Engelsen AST, Thiery J, Jamora C, Chouaib S. Role of Hypoxia-Mediated Autophagy in Tumor Cell Death and Survival. Cancers (Basel) 2021;13:533. [PMID: 33573362 DOI: 10.3390/cancers13030533] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 101 |
Yu H, Zhang D, Lian M. Identification of an epigenetic prognostic signature for patients with lower-grade gliomas. CNS Neurosci Ther 2021;27:470-83. [PMID: 33459509 DOI: 10.1111/cns.13587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 102 |
Wang N, Wang S, Wang X, Zheng Y, Yang B, Zhang J, Pan B, Gao J, Wang Z. Research trends in pharmacological modulation of tumor-associated macrophages. Clin Transl Med 2021;11:e288. [PMID: 33463063 DOI: 10.1002/ctm2.288] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 103 |
Lapuente-santana Ó, van Genderen M, Hilbers P, Finotello F, Eduati F. Predictive Systems Biomarkers of Response to Immune Checkpoint Inhibitors. SSRN Journal. [DOI: 10.2139/ssrn.3805194] [Reference Citation Analysis]
|
| 104 |
Ramos RI, Shaw MA, Foshag L, Stern SL, Rahimzadeh N, Elashoff D, Hoon DSB. Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients. Cancers (Basel) 2020;13:E91. [PMID: 33396862 DOI: 10.3390/cancers13010091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 105 |
Mikolajczyk TP, Szczepaniak P, Vidler F, Maffia P, Graham GJ, Guzik TJ. Role of inflammatory chemokines in hypertension. Pharmacol Ther 2021;223:107799. [PMID: 33359600 DOI: 10.1016/j.pharmthera.2020.107799] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 106 |
Hamarsheh S, Groß O, Brummer T, Zeiser R. Immune modulatory effects of oncogenic KRAS in cancer. Nat Commun 2020;11:5439. [PMID: 33116132 DOI: 10.1038/s41467-020-19288-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 101] [Article Influence: 27.7] [Reference Citation Analysis]
|
| 107 |
Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. J Inflamm Res 2020;13:619-33. [PMID: 33061527 DOI: 10.2147/JIR.S270872] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 108 |
Bruce JIE, James AD. Targeting the Calcium Signalling Machinery in Cancer. Cancers (Basel) 2020;12:E2351. [PMID: 32825277 DOI: 10.3390/cancers12092351] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
|
